BioSpace News Archive

Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will present at the following virtual investor conferences:

Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in fireside chats at the following upcoming virtual investor conferences

STERIS plc announced that is has completed the previously announced acquisition of Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2020, and provided a corporate update

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences

Align Technology, Inc. (Nasdaq: ALGN) today announced that it will host a virtual Investor Day on Monday, November 23, 2020, beginning at 8:00 a.m. Eastern time.

Stryker announced that it has priced an offering of $600 million aggregate principal amount of its 0.600% Notes due 2023.

Consonance-HFW Acquisition Corp. (“Consonance-HFW”) announced today the pricing of its initial public offering of 8,000,000 units, at a price to the public of $10.00 per unit, for aggregate gross proceeds of $80,000,000.

The Prostate Cancer Foundation and Movember announced two new Movember – PCF Challenge Awards.

Charles A. Stevens, JD, MBA, Chief Operating Officer of CoPilot Provider Support Services, a market leading provider of technologically advanced healthcare access solutions, moderated a panel exploring the future of oncology reimbursement support HUBs.